The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Investor
23.12.2025
New governance structure for Gpi
Fausto Manzana appointed Executive Chairman, Andrea Di Santo Chief Executive Officer
Investor
22.12.2025
Cerved Rating Agency confirms Gpi’s public rating
The rating is “A3.1”
Investor
03.12.2025
Tesi, kicks off the BILGAI project
Artificial intelligence and sensor technologies to innovate the blood supply chain
